PV_logo      
    Phenome Ventures, LLC  
   
     
 Partnering for Discovery
       

We are located in Seattle, Washington, but available worldwide

Contact us at: Info@PhenomeVentures.com

 

What is the “Phenome?”

The phenome describes how organisms – whether humans, other animals, plants, etc. – are the same or different based on genome sequences and the effects of life’s experiences and exposures. As never before, we can now determine whole genome sequences and measure a vast array of proteins, metabolites, microbiome effects, physiological functioning, immune system traits, and many other features from the single-cell to the whole organism levels.
 
 

How does understanding the phenome advance scientific discovery? Some examples:

Finding the earliest phases of dysregulation long prior to the clinical onset of disease when treatments can be most effective.

Understanding how people vary in disease susceptibility and drug responses for individualized medicine.

Similar insights for model organisms where we can perturbate and control variables.

Study of domesticated animals for a revolution in veterinary medicine and in animal husbandry.

Phenomics of plants for improving crop yields, pathogen resistance, and other desirable traits.

Insights into other broad areas, including the effects of environmental exposures to toxins, both manmade and naturally occurring, the patterns of human migration and evolution, biogeography of all types of organisms, and many others.

 
 

How can Phenome Ventures help?

We partner with academic or corporate clients to provide technical expertise for project design, proposal preparation, assay vendor choice and contracting, and data handling and interpretation.

Although we occasionally find collaborators with funds in hand, we start most projects by partnering with a team for a proposal without any charges with the expectation that our costs for project participation and analysis will be part of the proposal budget.

We are also available for consulting on a fee-for-service basis for those interested in using or investing in these technologies. We can create a customized business intelligence report for any specific need.

 
 

The principal of Phenome Ventures is Jeffrey L. Boore, Ph.D., whose experiences include:

(Details) Chief Biotechnology Officer, Phenome Health (Jan 2022-Oct 2024), a non-profit research institution devoted to the Human Phenome Initiative.

Responsible for implementing technology for high-throughput genomics, proteomics, clinical, wearable, single-cell, immunological, and microbiome assays, participating in organizational strategy, forming and managing strategic partnerships and collaborations, developing commercial opportunities, interfacing with the broader scientific community, participating in scientific interpretations, publications, and translation into clinical practice, and contributing to education and outreach to physicians, participants, and the public. Also a Senior Visiting Scientist at the Buck Institute for Research on Aging in Novato, CA.

(Details) Director of Translational Medicine for Providence St. Joseph Health (Jan 2017-Jan 2022), a large healthcare provider with 51 hospitals and 119,000 employees.

Responsible for forming and managing strategic partnerships among PSJH clinicians and researchers, building outside collaborations, implementing technology for translational medicine, to include high-throughput genomics, proteomics, and single cell assays, developing commercial opportunities, and interfacing with the broader scientific community.

(Details) Founder, Owner, and Chief Executive Officer of Genome Project Solutions, Inc. (2007-2015), a company dedicated to genome sequencing and analysis.

Led dozens of whole genome sequencing projects with both academic and corporate partners and built large-scale databases for their interpretation (see lists below under major scientific contributions).

(Details) Head of Comparative Genomics, scientist at Berkeley National Laboratory, and member of the Senior Management Team of the DOE Joint Genome Institute (2000-2007, and continuing as a Guest Researcher until 2015), one of the world's largest genome centers, with an annual budget of $65 million, and led an independently funded research laboratory.

Led JGI's transition from being a human genome sequencing facility to being a comparative genomics institute and JGI is, today, broadly acknowledged as premier in its sampling of phylogenetically diverse organisms and in their evolutionary comparisons. Led the development of the $20 million/year JGI Community Sequencing Program that provides genomic data to the scientific community through peer review.

(Details) Adjunct Professor at the University of California Berkeley (2001-2018).

Taught genome evolution, sponsored graduate students, postdoctoral researchers, and sabbatical visitors, managed many scientific collaborations with the national laboratory, and fully participated in academic life.

(Details) Major scientific contributions in addition to work in biomedicine

Led numerous whole genome sequencing projects, including those of the crustacean Daphnia pulex, the butterfly Danaus plexippus, the gastropod mollusks Potamopyrgus antipodarum, P. estuarinus and, P. kaitunuparaoa, the glaucophyte Cyanophora paradoxa, the moss Physcomitrella patens, the stramenopile alga Nannochloropsis gaditana, the green alga Chlorella vulgaris, and the oomycetes Phytophthora sojae and P. ramorum, and performed major parts of the analyses for the genomes of the fish Xiphophorus maculatus, the tunicate Ciona intestinalis, the bivalve mollusk Lottia gigantea, the annelids Helobdella robusta and Capitella teleta, and the oomycetes Pythium ultimum and Hyaloperonospora arabidopsidis.

Made significant contributions to understanding the genome duplications at the base of the vertebrates, the evolutionary transfer of genes among intracellular compartments, modes of genome rearrangement, mammalian sex chromosome evolution, Hox gene cluster evolution, recognizing regulatory elements in DNA sequences, using genome-level characters for reconstructing evolutionary relationships, evaluating changes in gene expression patterns, understanding the effects of various genome processes on DNA sequence evolution, and identifying the genomic underpinnings of plant pathogenesis and environmental adaptation, crop improvement, biofuels production, responses to environmental challenges, behavioral complexity, asexuality within lineages, and differential longevity among populations.

Early work on organellar genomes determined the complete mtDNA sequences of ~200 species and cpDNA sequences of ~100 species. The results addressed questions of genome evolution, deep evolutionary relationships, intron evolution, post-transcriptional modification of tRNAs, gene movements among intracellular compartments, changes in the genetic code, and the evolution of codon usage patterns.

Two examples of software created by my group include DOGMA (Dual Organellar Genome Annotator), which provides a semi-automated tool for identifying and annotating genes for mitochondrial and plastid genomes. Second is PHRINGE (Phylogenetic Resources for the Interpretation of Genomes), which accepts the complete gene sets of many genomes, clusters these into families using a unique algorithm, creates true phylogenetic trees for each cluster, and has an extensive set of databases, displays, and queries for comparing homologous genes across these genomes. This has been shown to be the most accurate method for assigning gene function based on inference of homology, the only possible evidence in the absence of genetic or biochemical experimentation.

Through all of these these experiences, authored 130 published manuscripts that have been collectively cited in the scientific literature nearly 40,000 times, led 23 grant-funded projects totaling over $12 million, trained scores of postdoctoral scholars, graduate students, and visiting researchers, delivered over 280 scientific presentations, and served on numerous advisory boards and panels, including those to the National Science Foundation (NSF), US Department of Agriculture (USDA), National Institutes of Health (NIH), and the National Evolutionary Synthesis Center.